Thomas A. Lutz

18.7k total citations
421 papers, 12.8k citations indexed

About

Thomas A. Lutz is a scholar working on Endocrine and Autonomic Systems, Physiology and Surgery. According to data from OpenAlex, Thomas A. Lutz has authored 421 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Endocrine and Autonomic Systems, 130 papers in Physiology and 102 papers in Surgery. Recurrent topics in Thomas A. Lutz's work include Regulation of Appetite and Obesity (150 papers), Diet and metabolism studies (76 papers) and Pancreatic function and diabetes (56 papers). Thomas A. Lutz is often cited by papers focused on Regulation of Appetite and Obesity (150 papers), Diet and metabolism studies (76 papers) and Pancreatic function and diabetes (56 papers). Thomas A. Lutz collaborates with scholars based in Switzerland, Germany and United States. Thomas A. Lutz's co-authors include Thomas Riediger, E. Scharrer, Stephen C. Woods, Marco Bueter, Christina N. Boyle, Eleonora Del Prete, Csilla Becskei, Christelle Le Foll, Nori Geary and Carel W. le Roux and has published in prestigious journals such as Nature Communications, Physiological Reviews and SHILAP Revista de lepidopterología.

In The Last Decade

Thomas A. Lutz

412 papers receiving 12.5k citations

Peers

Countries citing papers authored by Thomas A. Lutz

Since Specialization

Citations

This map shows the geographic impact of Thomas A. Lutz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Lutz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Lutz more than expected).

Fields of papers citing papers by Thomas A. Lutz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Lutz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Lutz. The network helps show where Thomas A. Lutz may publish in the future.

Co-authorship network of co-authors of Thomas A. Lutz

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Lutz. A scholar is included among the top collaborators of Thomas A. Lutz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Lutz. Thomas A. Lutz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Expanding epidemic of recently acquired HCV in HIV-coinfected patients over a period of 10 years 2023 ·JHEP Reports ·Christiana Graf, Lara Fuhrmann, Thomas A. Lutz, Christoph Stephan, Gaby Knecht, Peter Gute, Markus Bickel, Kai‐Henrik Peiffer, Fabian Finkelmeier, G. Dultz, A. W. Mondorf, Nils Wetzstein, Natalie Filmann, Eva Herrmann, Stefan Zeuzem, Niko Beerenwinkel, Julia Dietz, Christoph Sarrazin	2
2	A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models 2023 ·Nature Communications ·(unknown), Fabrice D. Heitz, (unknown), (unknown), Karin Breu, Heather C. Denroche, Julien Thévenet, Melania Osto, Paolo Arosio, Julie Kerr‐Conte, C. Bruce Verchere, François Pattou, Thomas A. Lutz, Marc Y. Donath, Christoph Höck, Roger M. Nitsch, Jan Grimm	13
3	Calcitonin receptor antibody validation and expression in the rodent brain 2022 ·Cephalalgia ·Erica R. Hendrikse, Tayla A. Rees, (unknown), Christelle Le Foll, Thomas A. Lutz, Andrew Siow, Peter J. Wookey, Christopher S. Walker, Debbie L. Hay	12
4	Geospatial technologies for an automated holistic risk assessment of UAS operations 2022 ·Gernot Paulus, Dariia Strelnikova, Thomas A. Lutz, Karl–Heinrich Anders, (unknown), (unknown), (unknown), (unknown)	1
5	Characterization of Antibodies against Receptor Activity-Modifying Protein 1 (RAMP1): A Cautionary Tale 2022 ·International Journal of Molecular Sciences ·Erica R. Hendrikse, Tayla A. Rees, (unknown), Michael L. Garelja, Andrew Siow, Paul W. R. Harris, John B. Pawlak, Kathleen M. Caron, (unknown), Andrew F. Russo, Levi P. Sowers, Thomas A. Lutz, Christelle Le Foll, Christopher S. Walker, Debbie L. Hay	8
6	Whole‐brain mapping of amylin‐induced neuronal activity in receptor activity–modifying protein 1/3 knockout mice 2021 ·European Journal of Neuroscience ·(unknown), Urmas Roostalu, Henrik H. Hansen, Thomas A. Lutz, Christelle Le Foll, Casper G. Salinas, Jacob Lercke Skytte, Jacob Jelsing, Niels Vrang, Jacob Hecksher‐Sørensen	13
7	Serum insulin-like growth factor-1 concentrations in healthy cats before and after weight gain and weight loss 2021 ·Journal of Veterinary Internal Medicine ·Eric Zini, (unknown), (unknown), (unknown), Thomas A. Lutz, Claudia E Reusch	4
8	Oleoylethanolamide decreases frustration stress-induced binge-like eating in female rats: a novel potential treatment for binge eating disorder 2020 ·Neuropsychopharmacology ·Adele Romano, Maria Vittoria Micioni Di Bonaventura, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Emanuela Micioni Di Bonaventura, Caterina Scuderi, Annabella Vitalone, Antonella Tramutola, Fabio Altieri, Thomas A. Lutz, Anna Maria Giudetti, Tommaso Cassano, Carlo Cifani, Silvana Gaetani	39
9	Glycemic variability in newly diagnosed diabetic cats treated with the glucagon-like peptide-1 analogue exenatide extended release 2020 ·Journal of Veterinary Internal Medicine ·(unknown), (unknown), Federico Fracassi, Felicitas S. Boretti, Nadja S. Sieber‐Ruckstuhl, Thomas A. Lutz, Barbara Contiero, Eric Zini, Claudia E Reusch	14
10	Diabetic cats have decreased gut microbial diversity and a lack of butyrate producing bacteria 2019 ·Scientific Reports ·(unknown), Melania Osto, (unknown), Lara Puetz, M. Thomas P. Gilbert, Torben Hansen, Oluf Pedersen, Claudia E Reusch, Eric Zini, Thomas A. Lutz, Charlotte Reinhard Bjørnvad	54
11	Brainstem GLP-1 signalling contributes to cancer anorexia-cachexia syndrome in the rat 2017 ·Neuropharmacology ·Tito Borner, (unknown), Thomas A. Lutz, Thomas Riediger	27
12	THU0504 Quantifying physical education attendance and its relationship to pain severity and fatigue in adolescents with juvenile idiopathic arthritis – results from the german national paediatric rheumatological database 2017 ·Annals of the Rheumatic Diseases ·(unknown), Martina Niewerth, (unknown), (unknown), Christoph Rietschel, Thomas A. Lutz, (unknown), (unknown)	2
13	Estrogenic suppression of binge‐like eating elicited by cyclic food restriction and frustrative‐nonreward stress in female rats 2017 ·International Journal of Eating Disorders ·Maria Vittoria Micioni Di Bonaventura, Thomas A. Lutz, Adele Romano, Mariangela Pucci, Nori Geary, Lori Asarian, Carlo Cifani	53
14	Protocol for a prospective, controlled, observational study to evaluate the influence of hypoxia on healthy volunteers and patients with inflammatory bowel disease: the Altitude IBD Study 2017 ·BMJ Open ·Stephan R. Vavricka, Pedro A. Ruiz, Sylvie Scharl, Luc Biedermann, Michael Scharl, Cheryl de Vallière, (unknown), Roland H. Wenger, Leonhard Held, Tobias M. Merz, Max Gassmann, Thomas A. Lutz, Andres Kunz, (unknown), A. Fontana, Laura Strauss, Achim Weber, Michael Fried, Gerhard Rogler, Jonas Zeitz	7
15	Treatment of HCV genotype 2 with sofosbuvir and ribavirin results in lower sustained virological response rates in real life than expected from clinical trials 2016 ·Liver International ·Frank Tacke, Rainer Günther, Peter Buggisch, Hartwig Klinker, Andreas Schober, (unknown), Thomas A. Lutz, (unknown), Claus Niederau, Markus Cornberg, Christoph Sarrazin, Stefan Mauss	30
16	Translational value of animal models of obesity—Focus on dogs and cats 2015 ·European Journal of Pharmacology ·Melania Osto, Thomas A. Lutz	41
17	Reduced Insulin Sensitivity as a Marker for Acute Mountain Sickness? 2013 ·High Altitude Medicine & Biology ·(unknown), (unknown), Isabelle Herter‐Aeberli, Max Gassmann, Wolfgang Langhans, Marco Maggiorini, Thomas A. Lutz, Oliver Goetze	12
18	Wohin geht die Anti-Obesitas Therapie? 2012 ·Thomas A. Lutz, Marco Bueter	1
19	[636] THE INFLUENCE OF NUCLEOSIDE FREE HAART ON THE TREATMENT OF CHRONIC HEPATITIS C WITH PEGYLATED INTERFERON/RIBAVIRIN COMBINATION TREATMENT 2007 ·Journal of Hepatology ·Jürgen K. Rockstroh, (unknown), M. Vogel, Gerd Klausen, Thomas A. Lutz, Dirk Schuermann, Amina Carlebach, Christoph Mayr, (unknown), Peter Buggisch, (unknown), C John, (unknown), S Staszewski	1
20	Inhibition of Central Amylin Signaling Increases Food Intake and Body Adiposity in Rats 2001 ·Endocrinology ·Paul A. Rushing, Mary M. Hagan, Randy J. Seeley, Thomas A. Lutz, David A. D’Alessio, Ellen L. Air, Stephen C. Woods	130

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact